W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

X

News

26 March, 2026
89. Collection of medical, cost, financial, and accounting data on services related to eye diseases, endocrine system disorders, and highly specialized services
read more
16 February, 2026
87. Collection of medical and cost data on services related to pregnancy and childbirth (JGP section N)
read more
17 April, 2026
Publication AWA
read more
17 April, 2026
Status of work
read more
17 April, 2026
/ The Transparency Council meeting 18/2026 on 27 April 2026
read more
17 April, 2026
Recommendation of the President – Prevenar 20
read more
14 April, 2026
Communication of the meeting of Transparency Council No. 14/2026 on 7 April 2026 with resolutions
read more
14 April, 2026
Communication of the meeting of Transparency Council No. 14/2026 on 7 April 2026 with resolutions
read more
10 April, 2026
Publication AWA
read more
10 April, 2026
Status of work
read more
10 April, 2026
Communication of the meeting of Transparency Council No. 13/2026 on 30 March with resolutions
read more
07 April, 2026
The Transparency Council meeting 15/2026 on 13 April 2026
read more
07 April, 2026
Recommendation of the President – Skyrizi (risankizumab)
read more
03 April, 2026
Publication AWA
read more
03 April, 2026
Status of work
read more
02 April, 2026
Tariff Council meeting 3/2026 on 9 April 2026
read more
02 April, 2026
Tariff Council meeting 5/2026 on 16 April 2026
read more
31 March, 2026
Recommendation of the President – next-generation sequencing of the human genom
read more
31 March, 2026
Recommendation of the President – fundus examination using a fundus camera, with screening for diabetic retinopathy performed by a diabetologist or ophthalmologist or using artificial intelligence software
read more
31 March, 2026
The Transparency Council meeting 14/2026 on 7 April 2026
read more
27 March, 2026
Status of work
read more
27 March, 2026
Recommendation of the President – Apixaban Adamed (apixaban)
read more
27 March, 2026
Recommendation of the President – Embavi (apixaban)
read more
26 March, 2026
Communication of the meeting of Transparency Council No. 12/2026 on 23 March 2026 with resolutions
read more

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności announcement of the President azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council Tarification Plan 2025 tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy

Pokaż więcej ↓

Pokaż mniej ↑